Cargando…
BCL-XL blockage in TNBC models confers vulnerability to inhibition of specific cell cycle regulators
Cell cycle regulators are frequently altered in Triple-Negative Breast Cancer (TNBC). Emerging agents targeting these signals offer the possibility to design new combinatorial therapies. However, preclinical models that recapitulate TNBC primary resistance and heterogeneity are essential to evaluate...
Autores principales: | Castellanet, Olivier, Ahmad, Fahmida, Vinik, Yaron, Mills, Gordon B., Habermann, Bianca, Borg, Jean-Paul, Lev, Sima, Lamballe, Fabienne, Maina, Flavio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490507/ https://www.ncbi.nlm.nih.gov/pubmed/34646365 http://dx.doi.org/10.7150/thno.60503 |
Ejemplares similares
-
The AXL-PYK2-PKCα axis as a nexus of stemness circuits in TNBC
por: Khera, Lohit, et al.
Publicado: (2021) -
Modeling Heterogeneity of Triple‐Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance
por: Lamballe, Fabienne, et al.
Publicado: (2020) -
Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis
por: Verma, Nandini, et al.
Publicado: (2020) -
Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL Inhibition
por: Rahman, Masum, et al.
Publicado: (2022) -
Anti‐apoptotic protein BCL‐XL as a therapeutic vulnerability in gastric cancer
por: Wei, Yumin, et al.
Publicado: (2023)